S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
NASDAQ:AKLI

Akili (AKLI) Stock Price, News & Analysis

$0.38
-0.03 (-7.26%)
(As of 02/29/2024 ET)
Today's Range
$0.38
$0.41
50-Day Range
$0.22
$0.52
52-Week Range
$0.19
$2.08
Volume
1.06 million shs
Average Volume
3.47 million shs
Market Capitalization
$30.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Akili MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
943.3% Upside
$4.00 Price Target
Short Interest
Healthy
0.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.52mentions of Akili in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.86) to ($0.53) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.65 out of 5 stars

Medical Sector

275th out of 959 stocks

Surgical & Medical Instruments Industry

32nd out of 97 stocks


AKLI stock logo

About Akili Stock (NASDAQ:AKLI)

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

AKLI Stock Price History

AKLI Stock News Headlines

Preview: Akili's Earnings
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Akili's ADHD digital therapy seeks Japan approval
Akili (AKLI) Scheduled to Post Quarterly Earnings on Thursday
Why Is Akili (AKLI) Stock Up 110% Today?
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Akili Inc Ordinary Shares
Akili Inc Ordinary Shares AKLI
Akili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcript
See More Headlines
Receive AKLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akili and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/11/2023
Today
2/29/2024
Next Earnings (Confirmed)
2/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AKLI
Fax
N/A
Employees
66
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+943.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,960,000.00
Net Margins
-6,265.48%
Pretax Margin
-6,263.65%

Debt

Sales & Book Value

Annual Sales
$1.04 million
Book Value
$1.42 per share

Miscellaneous

Free Float
62,335,000
Market Cap
$30.02 million
Optionable
Optionable
Beta
1.78
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Walter Edward Martucci II (Age 42)
    Ph.D., Co-Founder & Chairman
    Comp: $654.36k
  • Mr. Matthew Franklin M.B.A. (Age 50)
    President, CEO & Director
    Comp: $506.39k
  • Dr. Adam Gazzaley M.D. (Age 55)
    Ph.D., Co-Founder, Chief Science Advisor & Director
    Comp: $100k
  • Ms. Jacqueline L. Studer J.D. (Age 65)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $512.7k
  • Ms. Caty Reid
    VP of Marketing & Communications
  • Dr. Scott H. Kollins Ph.D.
    Chief Medical Officer
  • Mr. Jonathan David (Age 46)
    Chief Product Officer














AKLI Stock Analysis - Frequently Asked Questions

Should I buy or sell Akili stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Akili in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AKLI shares.
View AKLI analyst ratings
or view top-rated stocks.

What is Akili's stock price target for 2024?

1 Wall Street analysts have issued 1 year price targets for Akili's shares. Their AKLI share price targets range from $4.00 to $4.00. On average, they anticipate the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 943.3% from the stock's current price.
View analysts price targets for AKLI
or view top-rated stocks among Wall Street analysts.

How have AKLI shares performed in 2024?

Akili's stock was trading at $0.4871 at the beginning of the year. Since then, AKLI shares have decreased by 21.3% and is now trading at $0.3834.
View the best growth stocks for 2024 here
.

Are investors shorting Akili?

Akili saw a decrease in short interest in February. As of February 15th, there was short interest totaling 47,000 shares, a decrease of 24.1% from the January 31st total of 61,900 shares. Based on an average daily volume of 2,230,000 shares, the short-interest ratio is currently 0.0 days. Approximately 0.1% of the shares of the company are short sold.
View Akili's Short Interest
.

How were Akili's earnings last quarter?

Akili, Inc. (NASDAQ:AKLI) released its quarterly earnings data on Thursday, May, 11th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.04. The business earned $0.11 million during the quarter. Akili had a negative net margin of 6,265.48% and a negative trailing twelve-month return on equity of 76.97%.

Who are Akili's major shareholders?

Akili's stock is owned by many different institutional and retail investors. Top institutional investors include StoneX Group Inc. (1.36%), Longitude Cayman Ltd. (0.26%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jacqueline Studer, Matthew Franklin, Santosh Shanbhag and Walter Edward Martucci II.
View institutional ownership trends
.

How do I buy shares of Akili?

Shares of AKLI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AKLI) was last updated on 3/1/2024 by MarketBeat.com Staff